Tag:
Acurox
Latest Headlines
Latest Headlines
Acura shares spike on FDA painkiller approval, $20M Pfizer milestone
Acura Pharmaceuticals' two-and-a-half year saga to get a new opioid painkiller approved by the FDA has finally been capped with success. Late Friday the agency quietly handed out an approval for
King, Acura pain drug granted priority review
Acura Pharmaceuticals and King Pharmaceuticals have received FDA priority review status for the abuse-resistant pain drug Acurox. An expert panel previously rejected it after raising questions about
Pfizer buys King for its 'abuse-proof' slow release technology
If you need more proof of the value of new drug delivery methods, look at this week’s news about Pfizer paying $3.6 billion to buy King Pharmaceutical. King does many things, but what made King
In 19-1 vote, FDA panel rejects Acurox
Acura Pharmaceuticals and King Pharmaceuticals were handed a widely expected FDA expert panel rejection yesterday for their pain drug Acurox. In a 19 to 1 vote, the committee determined that the
Acura shares slide on stinging FDA staff review of Acurox
Shares of Acura Pharmaceuticals ( NASDAQ: ACUR ) tumbled 21 percent after staffers at the FDA questioned whether its pain drug, Acurox, was actually designed to deter abuse or simply negatively
Acura, King: FDA doesn't need new trials for Acurox
Acura Pharmaceuticals and King Pharmaceuticals, partners on drug Acurox, may be able to get the pain drug through an FDA review without more clinical data. After a meeting on Wednesday, the companies
